Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial

JACC: Cardiovascular Interventions

Volumn 7, Issue 8, 2014, Pages 849-856

  Di Lorenzo, Emilio ^a   Sauro, Rosario ^a   Varricchio, Attilio ^a   Capasso, Michele ^a   Lanzillo, Tonino ^a   Manganelli, Fiore ^a   Carbone, Giannignazio ^a   Lanni, Francesca ^a   Pagliuca, Maria Rosaria ^a   Stanco, Giovanni ^a   Rosato, Giuseppe ^a   Suryapranata, Harry ^b   De Luca, Giuseppe ^c,d  

^a Division of Cardiology   (Italy)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

everolimus eluting stent(s); primary angioplasty; sirolimus eluting stent(s); ST segment elevation myocardial infarction; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT; EVEROLIMUS;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEART DEATH; HEART DISEASE; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SIROLIMUS ELUTING STENT; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TARGET VESSEL REVASCULARIZATION; COMPARATIVE EFFECTIVENESS; CORONARY STENTING; DEVICE COMPARISON; DEVICE SAFETY; DEVICE THERAPY; EVEROLIMUS ELUTING CORONARY STENT; HEPARINIZATION; INTERVENTION STUDY; LOADING DRUG DOSE; MIDDLE AGED; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; SIROLIMUS ELUTING CORONARY STENT; SURGICAL MORTALITY; TERTIARY CARE CENTER; TREATMENT OUTCOME; ADVERSE EFFECTS; AGED; CORONARY THROMBOSIS; DEVICES; ITALY; KAPLAN MEIER METHOD; MORTALITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RECURRENT DISEASE; RISK FACTOR; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; EVEROLIMUS; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; RISK FACTORS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84906345862     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.02.016     Document Type: Article

References (25)

1. G. De Luca, E. Cassetti, and P. Marino Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction Am J Emerg Med 27 2009 712 719
2. G. De Luca, G. Biondi-Zoccai, and P. Marino transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials Ann Emerg Med 52 2008 665 676
3. G.W. Stone, C.L. Grines, D.A. Cox for the CADILLAC Investigators Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
4. G. De Luca, H. Suryapranata, and G.W. Stone et al. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials Int J Cardiol 126 2008 37 44
5. D. Antoniucci, A. Migliorini, and G. Parodi et al. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone Circulation 109 2004 1704 1706
6. H. Suryapranata, G. De Luca, and A.W. van 't Hof et al. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients Heart 91 2005 641 645
7. E. Di Lorenzo, G. De Luca, and R. Sauro et al. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) randomized trial J Am Coll Cardiol Intv 2 2009 515 523
8. E. Di Lorenzo, R. Sauro, and A. Varricchio et al. Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial Am Heart J 158 2009 e43 e50
9. G.W. Stone, B. Witzenbichler, G. Guagliumi for the HORIZONS-AMI Trial Investigators Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
10. M. Tebaldi, C. Arcozzi, G. Campo, G. Percoco, R. Ferrari, M. Valgimigli the STRATEGY Investigators The 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 54 2009 1900 1901
11. R. Violini, C. Musto, and F. De Felice et al. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial J Am Coll Cardiol 55 2010 810 814
12. A. Kaltoft, H. Kelbaek, and L. Thuesen et al. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) trial J Am Coll Cardiol 56 2010 641 645
13. J.Z. Atary, B.L. van der Hoeven, and S.S. Liem et al. Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study) Am J Cardiol 106 2010 4 12
14. M.A. Vink, M.T. Dirksen, and M.J. Suttorp et al. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial J Am Coll Cardiol Intv 4 2011 24 29
15. C. Spaulding, E. Teiger, and P. Commeau et al. Four-year follow-up of TYPHOON (Trial to Assess the Use of the Cypher Sirolimus-Eluting Coronary Stent in Acute Myocardial Infarction Treated With Balloon Angioplasty) J Am Coll Cardiol Intv 4 2011 14 23
16. M. Valgimigli, G. Campo, S. Gambetti for the MULTISTRATEGY Investigators Three-year follow-up of the Multicentre Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study (MULTISTRATEGY) Int J Cardiol 165 2013 134 141
17. G. De Luca, M. Valgimigli, and C. Spaulding et al. Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials J Thromb Thrombolysis 28 2009 200 210
18. G. De Luca, M.T. Dirksen, C. Spaulding for the DESERT Cooperation Drug-eluting vs bare metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials Arch Intern Med 172 2012 611 621
19. E.P. Navarese, J. Kubica, and F. Castriota et al. Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials EuroIntervention 7 2011 985 994
20. G. De Luca, N. Ernst, and A.W. van 't Hof et al. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction Am Heart J 151 2006 1256 1259
21. C.M. Gibson, J. Karha, S.A. Murphy for the TIMI Study Group Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis In Myocardial Infarction trials J Am Coll Cardiol 42 2003 7 16
22. L. Räber, H. Kelbæk, M. Ostojic for the COMFORTABLE AMI Trial Investigators Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial JAMA 308 2012 777 787
23. M. Sabate, A. Cequier, and A. Iñiguez et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
24. S.H. Hofma, J. Brouwer, and M.A. Velders et al. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial J Am Coll Cardiol 60 2012 381 387
25. G. De Luca, E.P. Navarese, and H. Suryapranata A meta-analytic overview of thrombectomy during primary angioplasty Int J Cardiol 166 2013 606 612